RxDoctor Payments Data

Kent Davis, MD

Facial Plastic Surgery · Houston, TXNPI 1972590644

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations.

$4,431in general payments, 2019–2025

Across 80 payments — averaging $55.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$966
  • Medtronic$757
  • Stryker$422
  • Optinose US, Inc.$384
  • Integra Lifesciences Corporation$350
  • GSK$259
  • plus $1K from 18 others

What the payments were for

  • Travel & lodging$90%
  • Food & beverage$4,421100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,431 in reported general payments places this provider in the 85th percentile of 42 facial plastic surgery providers in Texas.

See all facial plastic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$72,176
Medicare patients
174
Services billed
803

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine-FluticasoneAzelastine/Fluticasone18$2,114
Azelastine Hcl17$920
Ofloxacin17$457
Fluticasone Propionate26$351
Ipratropium Bromide11$275
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$223
Cefadroxil25$123
Methylprednisolone19$87

Paid to pharmacies, not to this prescriber.

Other facial plastic surgery in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →